Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ContraVir Pharmaceuticals Inc (NASDAQ:CTRV)

0.4813
Delayed Data
As of 2:21pm ET
 +0.0013 / +0.27%
Today’s Change
0.45
Today|||52-Week Range
2.32
-59.89%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization1.3K16.4K21.5K28.0K
 
 
 
 
 
 
Operating ExpensesGross Income-1.3K-16.4K-21.5K-28.0K
 
 
 
 
 
General Expenses1.7M13.9M20.6M21.0M
 
 
 
 
 
Research And Development314.2K8.4M15.0M13.7M
 
 
 
 
 
Total Operating Expenses1.7M14.0M20.6M21.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.7M-14.0M-20.6M-21.0M
 
 
 
 
 
Extraordinary Credit0.000.003.8M4.2M
 
 
 
Extraordinary Charge-3.6M-387.9K-214.0K0.00
 
 
 
 
Interest Expense On Debt12.9K0.00----
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.3M-14.3M-17.0M-16.8M
 
 
 
 
 
Income Taxes0.000.000.00-1.9M
 
 
Preferred Dividend0.00-7.8M0.000.00
 
 
Net Income-5.3M-14.3M-17.0M-14.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS12.8M21.8M27.1M58.3M
 
 
 
 
 
Shares To Calculate EPS Diluted12.8M21.8M27.1M58.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.41-$1.02-$0.63-$0.30
 
 
 
 
 
EPS Diluted-$0.41-$1.02-$0.63-$0.30